D. E. Shaw Research: Supercomputing & ML in Drug Discovery

Join GDG on Campus Zurich for an exclusive evening with D. E. Shaw Research (DESRES), based in New York City, which develops and uses advanced computational technologies to understand the behavior of biologically and pharmaceutically significant molecules at an atomic level of detail, and to design precisely targeted, highly selective drugs for the treatment of various diseases. Among its core technologies is Anton, a proprietary special-purpose supercomputer that DESRES designed and constructed to vastly accelerate the process of molecular dynamics simulation. DESRES uses Anton machines and high-speed commodity hardware, together with machine learning methods and other computational techniques, in both internal and collaborative drug discovery programs. Their team includes ML/AI researchers and engineers, computer scientists, applied mathematicians, computational chemists, biologists, and drug discovery scientists, all working collaboratively within a tightly coupled interdisciplinary environment. Two MIT-trained researchers and the Head of Recruiting are flying in from NYC to show you how they combine Machine Learning, Molecular Dynamics, and Custom Hardware to solve the world's toughest medical challenges. What’s in it for you? Deep Tech Talk: Insights into ML/AI for drug discovery from MIT PhDs.NYC Careers: Learn about internships and full-time roles in Manhattan.Networking: Connect with the DESRES team and the GDG community over Pizza. Agenda: 18:15 – Welcome & Intro by GDG on Campus Zurich18:30 – Tech Talk: ML & Anton Supercomputer19:15 – Career Q&A: Joining the NYC Team19:30 – Networking & Pizza Location: ETH Zurich, HG G 3. Capacity is limited! Register now to secure your spot.